Connect to share and comment

Fda cf drug

Appears In:
New med is the first to treat the genetic condition's underlying cause.
The agency plans to review the drug Wednesday.
The Food and Drug Administration has stopped pediatric trials of Amgen Inc's Sensipar after a 14-year-old patient died.
Fda cf drug
Stan Honda